China Warns of Retaliation for Countries Backing US Trade Tactics
China has issued a stark warning to nations weighing closer alignment with the US on trade policy, vowing “resolute” retaliation against any country that undermines Chinese interests to curry favor with Washington.
“China firmly opposes any party reaching a deal at the expense of China’s interests. If this happens, China will not accept it and will resolutely take reciprocal countermeasures,” the Ministry of Commerce said Monday.
The warning follows reports that the US has encouraged countries to restrict their trade with China in exchange for favorable tariff treatment. Although not officially stated, President Donald Trump hinted at this strategy in a recent interview, saying Latin American nations “maybe” should choose between American and Chinese investment.
Beijing cast such maneuvering as short-sighted and destabilizing.
“Appeasement will not bring peace, and compromise will not earn respect,” the ministry asserted, likening any concession to “negotiating with a tiger for its skin.” The statement described such deals as “selfish and shortsighted,” warning of inevitable “lose-lose” outcomes.
Beyond rhetoric, China has already demonstrated its willingness to act. In March, Beijing imposed tariffs of up to 100% on Canadian canola oil, pork, and other agricultural goods—moves widely interpreted as retaliation for Ottawa’s alignment with US trade restrictions. State media confirmed the sanctions served as a warning “not to make nice with Mr. Trump at China’s expense.”
As Washington eyes a more assertive trade posture, particularly toward China’s regional influence, Beijing has redoubled diplomatic outreach to prevent isolation. President Xi Jinping has hosted European leaders and toured Southeast Asia to promote “an open and cooperative international environment.” In Vietnam and Malaysia, he called for rejection of “decoupling” and “tariff abuse.”
Information for this briefing was found via The New York Times and the sources mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
